Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Piperacillin/tazobactam - NAEJA Pharmaceutical/Taiho Pharmaceutical

Drug Profile

Piperacillin/tazobactam - NAEJA Pharmaceutical/Taiho Pharmaceutical

Alternative Names: Tazobac; Tazobactam/piperacillin; Tazobactam/piperacillin 1:8 ratio product; Tazocel; Tazocilline; Tazocin; YP-18; Zosyn

Latest Information Update: 29 Oct 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NAEJA Pharmaceutical; Taiho Pharmaceutical
  • Developer FUJIFILM Toyama Chemical; Taiho Pharmaceutical
  • Class Antibacterials; Carboxylic acids; Penicillins; Piperazines
  • Mechanism of Action Beta lactamase inhibitors; Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Bacterial infections; Biliary tract infections; Cholangitis; Cholecystitis; Febrile neutropenia; Intra-abdominal infections; Nosocomial pneumonia; Peritonitis; Respiratory tract infections; Sepsis; Skin and soft tissue infections; Urinary tract infections

Most Recent Events

  • 01 Oct 2018 Taiho Pharmaceutical acquires marketing rights from Taisho Toyama Pharmaceutical for ZOSYN® in Japan
  • 24 Jun 2018 Biomarkers information updated
  • 19 May 2017 Launched for Skin and soft tissue infections in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top